20% subcutaneous immunoglobulin dosed biweekly for primary immunodeficiency

被引：4
|
作者：
Wasserman, Richard L. [1 ]
Stein, Mark R. [2 ]
Younger, M. Elizabeth M. [2 ]
Fatteh, Shahnaz [3 ]
Haddad, Elie [4 ,5 ]
机构：
[1] Allergy Partners North Texas Res, Dallas, TX USA
[2] Allergy Associates Palm Beaches, North Palm Beach, FL USA
[3] Larkin Community Hosp, South Miami, FL USA
[4] Univ Montreal, CHU St Justine, Dept Pediat, Montreal, PQ, Canada
[5] Univ Montreal, CHU St Justine, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2016年 / 117卷 / 01期
关键词：
REPLACEMENT THERAPY; EFFICACY; SAFETY; IGPRO20; DISEASE;
D O I：
10.1016/j.anai.2016.04.023
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetic Modeling and Simulation of Biweekly Subcutaneous Immunoglobulin Dosing in Primary Immunodeficiency
    Landersdorfer, Cornelia B.
    Bexon, Martin
    Edelman, Jonathan
    Rojavin, Mikhail
    Kirkpatrick, Carl M. J.
    Lu, Jianfeng
    Pfister, Marc
    Sidhu, Jagdev
    POSTGRADUATE MEDICINE, 2013, 125 (06) : 53 - 61
  • [2] 20% subcutaneous immunoglobulin for patients with primary immunodeficiency diseases: A systematic review
    Song, Jie
    Zhang, Lingli
    Li, Youping
    Quan, Shuyan
    Liang, Yi
    Zeng, Linan
    Liu, Yi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 25 (02) : 457 - 464
  • [3] Home Care Use of Intravenous and Subcutaneous Immunoglobulin for Primary Immunodeficiency in the United States
    Huang, Faith
    Feuille, Elizabeth
    Cunningham-Rundles, Charlotte
    JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 (01) : 49 - 54
  • [4] Overview of subcutaneous immunoglobulin 16.5% in primary and secondary immunodeficiency diseases
    Kobayashi, Roger H.
    Litzman, Jiri
    Rizvi, Syed
    Kreuwel, Huub
    Hoeller, Sonja
    Gupta, Sudhir
    IMMUNOTHERAPY, 2022, 14 (04) : 259 - 270
  • [5] Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents
    Suez, Daniel
    Krivan, Gergely
    Jolles, Stephen
    Stein, Mark
    Gupta, Sudhir
    Paris, Kenneth
    van Hagen, P. Martin
    Brodszki, Nicholas
    Engl, Werner
    Leibl, Heinz
    McCoy, Barbara
    Yel, Leman
    IMMUNOTHERAPY, 2019, 11 (12) : 1057 - 1065
  • [6] Subcutaneous immunoglobulin (16 or 20%) therapy in obese patients with primary immunodeficiency: a retrospective analysis of administration by infusion pump or subcutaneous rapid push
    Shapiro, R.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 173 (02): : 365 - 371
  • [7] Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency
    Gupta, Sudhir
    Kobayashi, Roger H.
    Litzman, Jiri
    Cherwin, Laurel
    Hoeller, Sonja
    Kreuwel, Huub
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (01) : 7 - 17
  • [8] Immune Globulin Subcutaneous (Human) 20% In Primary Immunodeficiency Disorders
    McCormack, Paul L.
    DRUGS, 2012, 72 (08) : 1087 - 1097
  • [9] Cost-minimization Analysis of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients With Primary Immunodeficiency
    Igarashi, Ataru
    Kanegane, Hirokazu
    Kobayashi, Midori
    Miyawaki, Toshio
    Tsutani, Kiichiro
    CLINICAL THERAPEUTICS, 2014, 36 (11) : 1616 - 1624
  • [10] Infusion parameters of 20% subcutaneous immunoglobulin for primary immunodeficiency diseases among patient support program participants
    Meckley, Lisa M.
    Wu, Yanyu
    Tzivelekis, Spiros
    Gandhi, Vivek
    Gladiator, Andre
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : 568 - +
12345